Discontinuation report TEVA-LAMIVUDINE/ZIDOVUDINE

Last updated on 2020-01-24 History
Report ID 104260
Drug Identification Number 02387247
Brand name TEVA-LAMIVUDINE/ZIDOVUDINE
Common or Proper name LAMIVUDINE/ZIDOVUDINE 150/300MG
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) ZIDOVUDINE LAMIVUDINE
Strength(s) 300MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-12-05
Remaining supply date 2019-12-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare

Showing 1 to 2 of 2